Copeptin Changes After Food Intake (CoMeal)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01772914
Recruitment Status : Completed
First Posted : January 21, 2013
Last Update Posted : May 20, 2014
Information provided by (Responsible Party):
Mirjam Christ-Crain, University Hospital, Basel, Switzerland

Brief Summary:
The purpose of this study is to determine whether copeptin levels are affected by food intake.

Condition or disease
Healthy Adults Copeptin

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test
Study Start Date : February 2013
Actual Primary Completion Date : June 2013
Actual Study Completion Date : February 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid [ Time Frame: 30, 60, 90, 120, 180 minutes after intake of the test liquids ]

Biospecimen Description:
Serum EDTA

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
healthy adults

Inclusion Criteria:

  • Aged over 18 years

Exclusion Criteria:

  • Intake of any kind of medication (except birth control pill)
  • BMI >30 kg/m2
  • Evidence of any acute illness
  • History of chronic illness
  • Pregnancy
  • Known galactosemia or maltose malabsorption
  • Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01772914

University Hospital Basel
Basel, Basel-Stadt, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Principal Investigator: Mirjam Christ-Crain,

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Mirjam Christ-Crain, Prof. Dr. med., University Hospital, Basel, Switzerland Identifier: NCT01772914     History of Changes
Other Study ID Numbers: CoMeal 2013
First Posted: January 21, 2013    Key Record Dates
Last Update Posted: May 20, 2014
Last Verified: January 2013

Keywords provided by Mirjam Christ-Crain, University Hospital, Basel, Switzerland:
glucose tolerance test
mixed meal test

Additional relevant MeSH terms:
Diabetes Insipidus
Kidney Diseases
Urologic Diseases
Pituitary Diseases
Endocrine System Diseases
Arginine Vasopressin
Vasoconstrictor Agents
Antidiuretic Agents
Natriuretic Agents
Physiological Effects of Drugs